ID PFFRM standard; DNA; INV; 843 BP. XX AC L40835; XX NI g725288 XX DT 13-APR-1995 (Rel. 43, Created) DT 24-AUG-1995 (Rel. 44, Last updated, Version 2) XX DE Plasmodium falciparum (clones BRA3-5b,-19a,-14b,-28e) liver DE stage-specific antigen 1 (LSA-1) gene, 3' end of cds. XX KW exoerythrocytic; liver stage-specific antigen; KW liver stage-specific antigen 1; Malaria. XX OS Plasmodium falciparum (malaria parasite) OC Eukaryotae; mitochondrial eukaryotes; Alveolata; Apicomplexa; OC Haemosporida; Plasmodium. XX RN [1] RP 1-843 RX MEDLINE; 96065765. RA Yang C., Shi Y.P., Udhayakumar V., Alpers M.P., Povoa M.M., RA Hawley W.A., Collins W.E., Lal A.A.; RT "Sequence variations in the non-repetitive regions of the liver RT stage-specific antigen-1 (LSA-1) of Plasmodium falciparum from RT field isolates"; RL Mol. Biochem. Parasitol. 71:291-294(1995). XX DR SPTREMBL; Q25853; Q25853. XX CC 1. Last author is Altaf A. Lal 2. The following clones have the sam CC e nucleotide sequence: BRA3-5b; BRA3-19a; BRA3-14b (one silent CC change at 5181, A to G) and BRA3-28e (one silent change at 5040, T CC to C) Clone name abbreviations: KEN for Kenya; PNG for Papua New CC Guinea and BRA for Brazil. For each clone, the number following the CC KEN, PNG or BRA represents group number, the number following the CC '-' denotes the patient's blood sample number and the lower case CC letter represents recombinant clones from the corresponding CC isolates. NCBI gi: 725288 XX FH Key Location/Qualifiers FH FT source 1..843 FT /organism="Plasmodium falciparum" FT /clone="BRA3-14b" FT /isolate="Kenyan" FT /dev_stage="blood stage parasite" FT /sequenced_mol="DNA" FT source 1..843 FT /organism="Plasmodium falciparum" FT /clone="BRA3-19a" FT /isolate="Kenyan" FT /dev_stage="blood stage parasite" FT /sequenced_mol="DNA" FT CDS <1..843 FT /gene="LSA-1" FT /note="NCBI gi: 950674" FT /codon_start=1 FT /product="liver stage-specific antigen 1" FT /db_xref="PID:g950674" FT /db_xref="SPTREMBL:Q25853" FT /translation="RKADTKKNLERKKEHGDVLAEDLYGRLEIPVIELPSEN ERGYYIP FT HQSSLPQDNRGNSRDSKEISIIEKTNRESITTNVEGRRDIHKGHLEEKKDGS IKPEQKE FT DKSADIQNHTLETVNISDVNDFQISKYEDEISAEYDDSLIDEEEDDEDLDEF KPIVQYD FT NFQDEENIGIYKELEDLIEKNENLDDLDEGIEKSSEELSEEKIKKGKKYEKT KDNNFKP FT NDKSLYDEHIKKYKNVKQVNKEKEKFIKSLFHIFDGDNEILQIVDELSEDIT KYFMKL" FT source 1..843 FT /organism="Plasmodium falciparum" FT /clone="BRA3-5b" FT /organism="Plasmodium falciparum" FT /clone="BRA3-5b" FT /isolate="Kenyan" FT /dev_stage="blood stage parasite" FT /sequenced_mol="DNA" FT source 1..843 FT /organism="Plasmodium falciparum" FT /clone="BRA3-28e" FT /isolate="Kenyan" FT /dev_stage="blood stage parasite" FT /sequenced_mol="DNA" FT source 1..843 FT /organism="Plasmodium falciparum" FT /clone="BRA3-29b" FT /isolate="Kenyan" FT /dev_stage="blood stage parasite" FT /sequenced_mol="DNA" FT mutation replace(75,"c") FT /gene="LSA-1" FT /note="clone BRA3-28e" FT mutation replace(216,"g") FT /gene="LSA-1" FT /note="clone BRA3-14b" XX SQ Sequence 843 BP; 397 A; 78 C; 153 G; 215 T; 0 other; aggaaggctg atacgaaaaa aaatttagaa agaaaaaagg aacatggaga tgtattagca 60 gaggatttat atggtcgttt agaaatacca gttatagaac ttccatcaga aaatgaacgt 120 ggatattata taccacatca atcttcttta cctcaggaca acagagggaa tagtagagat 180 tccaaggaaa tatctataat agaaaaaaca aatagagaat ctattacaac aaatgttgaa 240 ggacgaaggg atatacataa aggacatctt gaagaaaaga aagatggttc aataaaacca 300 gaacaaaaag aagataaatc tgctgacata caaaatcata cattagagac agtaaatatt 360 tctgatgtta atgattttca aataagtaag tatgaggatg aaataagtgc tgaatatgac 420 gattcattaa tagatgaaga agaagatgat gaagacttag acgaatttaa gcctattgtg 480 caatatgaca atttccaaga tgaagaaaac ataggaattt ataaagaact agaagatttg 540 atagagaaaa atgaaaattt agatgattta gatgaaggaa tagaaaaatc atcagaagaa 600 ttatctgaag aaaaaataaa aaaaggaaag aaatatgaaa aaacaaagga taataatttt 660 aaaccaaatg ataaaagttt gtatgatgag catattaaaa aatataaaaa tgttaagcag 720 gttaataagg aaaaggaaaa attcataaaa tcattgtttc atatatttga cggagacaat 780 gaaattttac agatcgtgga tgagttatct gaagatataa ctaaatattt tatgaaacta 840 taa 843 //